Botulinum Toxin Injections
J15 · Effective Feb 22, 2026
25 active Medicare policies list J0589, and 12 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
J5
12 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J0589 |
|---|---|---|
| Daxxify (daxibotulinumtoxinA-lanm) | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Daxxify (daxibotulinumtoxinA-lanm)Effective 01/01/2024 - 07/31/2024 | Jan 1, 2024 | Prior auth requiredInferred from policy title |
J8
J8 · Effective Feb 22, 2026
J9 · Effective Oct 1, 2015
JH · Effective Mar 21, 2021
JL · Effective Mar 21, 2021
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
J9 · Effective Nov 9, 2025
JH · Effective Nov 9, 2025
National · Effective Apr 9, 2026
| Daxxify (daxibotulinumtoxinA-lanm)Effective 08/01/2024 - 07/31/2025 | Aug 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Daxxify (daxibotulinumtoxinA-lanm)Effective 08/01/2025 - 07/31/2026 | Aug 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J0589 |
|---|---|---|
| DaxibotulinumtoxinA-lanm (Daxxify) | Jan 1, 2024 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0589 |
|---|---|---|
| DaxibotulinumtoxinA-lanm (Daxxify); CP.PHAR.651 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Botulinum toxins: abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), onabotulinumtoxinA (Botox), rimabotulinumtoxinB (Myobloc), and daxibotulinumtoxinA-lanm (Daxxify) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Daxxify (daxibotulinumtoxinA) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Botulinum Toxins A and B | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Botulinum Toxins A and B | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Botulinum Toxins A and B | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0589 |
|---|---|---|
| Treatment of Temporomandibular Joint (TMJ) | Not recorded | Covered |